APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma
Clinical trial NCT05186012 · UNKNOWN
Trial details
- NCT number
- NCT05186012
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-14
- Primary completion
- 2025-09-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.